{
    "2021-11-06": [
        [
            {
                "time": "",
                "original_text": "License in模式火热，上海医药、翰森制药月内达成两项合作",
                "features": {
                    "keywords": [
                        "License in模式",
                        "上海医药",
                        "翰森制药",
                        "合作"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "盘点 | 上海医药、罗欣药业、烨辉医药、翰森制药等多家公司引进新药，它们有何亮点？",
                "features": {
                    "keywords": [
                        "上海医药",
                        "罗欣药业",
                        "烨辉医药",
                        "翰森制药",
                        "新药",
                        "引进"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}